Table 2.
Present status | ||||||
Initial area of involvement | Duration of illness (years) | Focal n (%) | Segmental n (%) | Multifocal n (%) | Generalised n (%) | Parkinsonian n (%) |
Lower extremities | <2 | 4 (80) | 2 (17) | 2 (28) | 37 (53) | 0 |
n = 122 (33%) | 2–5 | 1 (20) | 5 (42) | 2 (28) | 25 (35) | 1 (4) |
5–10 | 0 | 3 (25) | 0 | 9 (12) | 4 (15) | |
10–15 | 0 | 1 (8) | 3 (44) | 0 | 2 (7) | |
>15 | 0 | 1 (8) | 0 | 0 | 20 (74) | |
Total | 5 | 12 | 7 | 71 | 27 | |
Upper extremities | <2 | 0 | 1 (25) | 0 | 13 (42) | 0 |
n = 52 (14%) | 2–5 | 0 | 1 (25) | 2 (40) | 14 (45) | 0 |
5–10 | 0 | 1 (25) | 1 (20) | 3 (10) | 1 (8) | |
10–15 | 0 | 1 (25) | 2 (40) | 1 (3) | 2 (17) | |
> 15 | 0 | 0 | 0 | 0 | 9 (75) | |
Total | 0 | 4 | 5 | 31 | 12 | |
Cervix and shoulder | <2 | 0 | 3 (25) | 0 | 29 (47) | 0 |
n = 92 (25%) | 2–5 | 2 (67) | 4 (33) | 2 (50) | 27 (43) | 2 (18) |
5–10 | 0 | 4 (33) | 0 | 5 (8) | 2 (18) | |
10–15 | 1 (33) | 0 | 2 (50) | 1 (2) | 4 (36) | |
>15 | 0 | 1 (9) | 0 | 0 | 3 (28) | |
Total | 3 | 12 | 4 | 62 | 11 | |
Trunk | <2 | 0 | 1 (50) | 0 | 1 (33) | 0 |
n = 5 (1%) | 2–5 | 0 | 1 (50) | 0 | 1 (33) | 0 |
5–10 | 0 | 0 | 0 | 1 (33) | 0 | |
10–15 | 0 | 0 | 0 | 0 | 0 | |
>15 | 0 | 0 | 0 | 0 | 0 | |
Total | 0 | 2 | 0 | 3 | 0 | |
Craniofacial | <2 | 0 | 1 (6) | 1 (20) | 24 (38) | 0 |
n = 102 (27%) | 2–5 | 1 (50) | 4 (25) | 2 (40) | 33 (52) | 2 (12) |
5–10 | 0 | 5 (31) | 1 (20) | 5 (8) | 1 (6) | |
10–15 | 1 (50) | 3 (19) | 0 | 1 (2) | 6 (38) | |
>15 | 0 | 3 (19) | 1 (20) | 0 | 7 (44) | |
Total | 2 | 16 | 5 | 63 | 16 |
One hundred and five patients died; the status of dystonia at time of death was considered.